What does this LOINC code represent?

This LOINC code identifies a lab observation, measurement, question, or clinical concept in a standardized format.

Is this enough to understand my test result?

No. The code identifies the test or observation, but the interpretation depends on the actual result, reference range, and clinical context.

LOINCActiveOrder

LOINC Code 72886-5: CYP2D6 gene and CYP2C19 gene targeted mutation analysis panel Molgen (Bld/Tiss)

Name: LOINC Code 72886-5: CYP2D6 gene and CYP2C19 gene targeted mutation analysis panel Molgen (Bld/Tiss)
Creator: HealthAssure Clinical Team
Published: 2026-05-21T08:59:51.525Z

72886-5 is a LOINC code used to identify CYP2D6 gene and CYP2C19 gene targeted mutation analysis panel Molgen (Bld/Tiss) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component CYP2D6 gene & CYP2C19 gene targeted mutation analysis panel. It is commonly used with the system or sample type Bld/Tiss.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component CYP2D6 gene & CYP2C19 gene targeted mutation analysis panel. It is commonly used with the system or sample type Bld/Tiss.

When is it used?

Used in lab systems, EHRs, and clinical data exchange.
May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
Status: ACTIVE
Order vs observation: Order
Panel type: Panel
Method: Molgen

What it does not mean

The code identifies the observation or test, not the actual result.

Key facts

CYP2D6 gene and CYP2C19 gene targeted mutation analysis panel - Blood or Tissue by Molecular genetics method

CYP2D6 gene & CYP2C19 gene targeted mutation analysis panel

CYP2D6 and CYP2C19 cytochrome P450 genes play a major role in the metabolism of many widely prescribed drugs, including anti-depressants, anti-psychotics, anti-epileptics, proton pump inhibitors, and beta-blockers. The CYP2D6 gene has at least 70 allelic variants resulting in four phenotypic typespoor metabolizers with gene inactivation of both alleles, intermediate metabolizers with one reduced activity allele and one null allele, extensive metabolizers with at least one functional allele, and ultra-rapid metabolizers with excess enzymatic activity due to multiple copies of functional alleles from gene duplication. The CYP2C19 gene has two major variant alleles that result in enzyme deficiency. This panel term is created for, but not limited to, Roche Diagnostics' AmpliChip CYP450 assay, which detects 29 polymorphisms in the 2D6 and 2 polymorphisms in the 2C19 gene, as well as gene duplications and deletions.

Blood; CPCJ; CPD6; CYP2C; CYP2D; CYP2D@; CYP2D6+CYP2C19; CYP2D6+CYP2C19 pnl; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; CYP2DL1; CYPIIC17; CYPIIC19; CYPIID6; Cytochrome p450; cytochrome P-450 II C; cytochrome P450, family 2, subfamily C, polypeptide 19; cytochrome P450, family 2, subfamily D, polypeptide 6; Debrisoquine hydroxylation gene; HGNC2629; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mutations; P450C2C; P450C2D; P450DB1; P450-DB1; P450IIC19; Pan; Panel.molpath; Panel.molpath.pharmg; Panl; PCR; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

CYP2D6 gene and CYP2C19 gene targeted mutation analysis panel Molgen (Bld/Tiss)CYP2D6 gene and CYP2C19 gene targeted mutation analysis panel - Blood or Tissue by Molecular genetics methodCYP2D6+CYP2C19 pnl Bld/TCYP2D6 gene & CYP2C19 gene targeted mutation analysis panelPANEL.MOLPATH.PHARMGCYP2D6 gene and CYP2C19 gene Targeted Mutation Analysis Panel, Blood or tissue specimen-

Frequently asked questions

Code details

Code72886-5

SystemLOINC

Display nameCYP2D6 gene and CYP2C19 gene targeted mutation analysis panel Molgen (Bld/Tiss)

DescriptionCYP2D6 gene & CYP2C19 gene targeted mutation analysis panel

Short nameCYP2D6+CYP2C19 pnl Bld/T

ComponentCYP2D6 gene & CYP2C19 gene targeted mutation analysis panel

Property-

TimingPt

System (specimen)Bld/Tiss

Scale-

MethodMolgen

ClassPANEL.MOLPATH.PHARMG

StatusACTIVE

Order/ObservationOrder

Flags

BillableNo

Valid clinical useNo

Source

SourceLOINC

Version2.82

Releasemain

First released2.44

Last changed2.67

Consumer names

CYP2D6 gene and CYP2C19 gene Targeted Mutation Analysis Panel, Blood or tissue specimen

Part names

CYP2D6 gene & CYP2C19 gene targeted mutation analysis panel-PtBld/TissMolgenCYP2D6 gene and CYP2C19 gene targeted mutation analysis panelPoint in time (spot)Blood or TissueMolecular genetics

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.